Description
GLYCINORM-MR 30 mg Tablets (30’s)
GLYCINORM-MR 30 mg Tablets contain Gliclazide, a second-generation sulfonylurea antidiabetic agent used in the management of type 2 diabetes mellitus. This medication helps control blood glucose levels by stimulating insulin secretion from pancreatic beta cells and improving peripheral insulin sensitivity.
The “MR” (Modified Release) formulation ensures a gradual and sustained release of the active ingredient over time, providing effective blood sugar control with once-daily dosing. This helps maintain stable glucose levels throughout the day and reduces the risk of hypoglycemia compared to immediate-release formulations.
GLYCINORM-MR is typically prescribed alongside diet and exercise to enhance glycemic control in patients inadequately managed with lifestyle changes alone.
Key Features:
-
Contains 30 mg Gliclazide in a modified-release form
-
Provides sustained and controlled blood glucose regulation
-
Supports insulin secretion and improves insulin sensitivity
-
Once-daily dosing for better compliance and convenience
-
Helps reduce risk of hypoglycemia compared to immediate-release sulfonylureas
-
Pack of 30 tablets for one-month treatment supply
Usage:
Take as prescribed by a healthcare professional. Regular blood sugar monitoring is recommended.
Reviews
There are no reviews yet.